Actively Recruiting
Doxycycline in Type II Diabetes
Led by Mostafa Bahaa · Updated on 2025-04-04
60
Participants Needed
1
Research Sites
107 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease characterized by hyperglycemia, weight loss, and cardio-metabolic complications. T2DM develops due to the progression of insulin resistance (IR), impairment of insulin insensitivity, and failure of the pancreatic β-cells to release sufficient amount of insulin in response to glucose burden
CONDITIONS
Official Title
Doxycycline in Type II Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged more than 40 years
- Newly diagnosed with type 2 diabetes
- HbA1c level higher than 6.5
You will not qualify if you...
- Chronic kidney disease
- Liver disorders
- Mental and psychiatric disorders
- Pregnancy
- Lactation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tanta Unuversity
Tanta, Egypt, 31527
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here